Dabigatran Etexilate Capsules: recall status

⚠ Recalls found. Dabigatran Etexilate Capsules is named in 6 official recalls in our current data:

• FDA Class III recall D-0737-2026 — Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
• FDA Class III recall D-0738-2026 — Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
• FDA Class III recall D-0739-2026 — Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
• And 3 more listed below.